--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-23-226362" form_type: "8-K" ticker: "SCLX" cik: "0001820190" company_name: "Scilex Holding Co" filed_at: "2023-08-31T23:59:59+00:00" generated_at: "2026-06-11T01:24:04.379354+00:00" event_type: "leadership" sentiment: "neutral" materiality_score: 0.85 calibrated_materiality_score: 0.85 confidence: "high" source: SEC EDGAR --- # Scilex board and CEO resign amid Oramed transaction; Dr. Lee resigns immediately ## Summary - Tien-Li Lee, M.D. resigned from the Board effective Aug 27, 2023, no disagreement. - Henry Ji, Ph.D. removed as director by Sorrento's CRO; will resign as executive officer upon Oramed closing. - CEO Jaisim Shah to retire from Board and CEO role effective upon Oramed closing. - Directors Hamill, Followwill, Lemus resign contingent on Oramed closing (no disagreement). - Oramed Transaction approved by Bankruptcy Court; expected close on or before Sept 30, 2023. ## SEC filing metadata - accession: 0001193125-23-226362 - form_type: 8-K - ticker: SCLX - cik: 0001820190 - company_name: Scilex Holding Co - filed_at: 2023-08-31T23:59:59+00:00 - event_type: leadership - sentiment: neutral - materiality_score: 0.85 - calibrated_materiality_score: 0.85 - confidence: high - sec_items: 5.02, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/d533212d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-23-226362 - JSON: https://secwatch.observer/filing/0001193125-23-226362.json - Plain text: https://secwatch.observer/filing/0001193125-23-226362.txt ## Key facts - Executive change Tien-Li Lee resigned as Director at Scilex Holding Co. - Action: resigned - Role: Director source text: On August 27, 2023, Tien-Li Lee, M.D. notified the Board of Directors (the “Board”) of the Company that he was resigning from the Board, all committees of the Board and any director or officer position held with any subsidiary of the Company, effective as of August 27, 2023. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - Executive change David Lemus resigned as Director at Scilex Holding Co. - Action: resigned - Role: Director source text: On August 28, 2023, each of Dorman Followwill and David Lemus notified the Board that he was resigning from the Board, all committees of the Board and any director or officer position held with any subsidiary of the Company, effective as of and contingent upon the closing of the Oramed Transaction. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - Executive change Dorman Followwill resigned as Director at Scilex Holding Co. - Action: resigned - Role: Director source text: On August 28, 2023, each of Dorman Followwill and David Lemus notified the Board that he was resigning from the Board, all committees of the Board and any director or officer position held with any subsidiary of the Company, effective as of and contingent upon the closing of the Oramed Transaction. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - Executive change Henry Ji resigned as Executive Officer at Scilex Holding Co. - Action: resigned - Role: Executive Officer source text: On August 27, 2023, Dr. Ji notified the Board that he was resigning from his position as an executive officer of the Company and any position as a director or officer of any subsidiary of the Company, effective as of and contingent upon the closing of the Oramed Transaction. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - Executive change Henry Ji was removed as Director at Scilex Holding Co. - Action: removed - Role: Director source text: On August 27, 2023, Henry Ji, Ph.D. was informed that, pursuant to Article V.E. of the Company’s Restated Certificate of Incorporation, the chief restructuring officer on behalf of Sorrento in its pending bankruptcy proceedings, as the holder of a majority in voting power of the then-outstanding shares of stock of the Company entitled to vote generally in the election of directors, had taken action by written consent to remove Dr. Ji as a director of the Company, effective as of such date. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - Executive change Laura J. Hamill resigned as Director at Scilex Holding Co. - Action: resigned - Role: Director source text: On August 27, 2023, Laura J. Hamill notified the Board that she was resigning from the Board, all committees of the Board and any director or officer position held with any subsidiary of the Company effective as of and contingent upon the closing of the Oramed Transaction. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm - Executive change Jaisim Shah retired as Chief Executive Officer and President at Scilex Holding Co. - Action: retired - Role: Chief Executive Officer and President source text: On August 29, 2023, Jaisim Shah notified the Board that he was retiring from the Board, all committees of the Board, his position as the Chief Executive Officer and President of the Company and any position as a director or officer of any subsidiary of the Company, effective as of and contingent upon the closing of the Oramed Transaction. evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312523226362/0001193125-23-226362-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.